Santosh T. Varghese

Dr. Varghese has been the company’s Senior Vice President, Chief Medical Officer since February 2020. Prior to that, beginning in January 2016, Dr. Varghese served as the company’s Vice President, Chief Medical Officer. From October 2013 to December 2015, Dr. Varghese served as the company’s Vice President, Medical & Regulatory Affairs, Pharmacovigilance, and QA. He joined the company in March 2012 as Vice President, Head of Medical Affairs. Prior to joining the company, Dr. Varghese was Senior Vice President, Medical Affairs at Élan Pharmaceuticals where he led Medical Affairs teams responsible for the BioNeurology portfolio. He held the position of Vice President Primary Care & Cardiovascular in Global Medical Affairs at Schering-Plough/Merck, and also held senior roles at Aventis/Sanofi-Aventis where he contributed to both US and global brand strategy and tactics. Dr. Varghese has served on the Board of Directors of the American Lung Association - New York and was on faculty at Touro University College of Medicine (now New York Medical College). Dr. Varghese earned his M.D. from St. George's University School of Medicine and a B.S. in Biology from Pennsylvania State University. He completed his medical training in the Caribbean, United States, and United Kingdom.